Send to

Choose Destination
Obstet Gynecol. 1994 Mar;83(3):445-8.

The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.

Author information

Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.



To determine the association between pretreatment platelet count and survival in women with stage IB cervical cancer.


Clinical records were reviewed for 219 women with stage IB cervical cancer treated by radical hysterectomy from 1971-1984. Univariate and multivariate analyses were performed to identify clinicopathologic variables associated with poor survival. Survival as a function of the preoperative platelet count was analyzed further and corrected for known prognostic factors.


The cumulative 5-year survival of women with a preoperative platelet count greater than 300,000/microL (n = 85) was 65%, as compared to 84% for a count equal to or less than 300,000/microL (n = 134) (P = .004). Univariate Cox regression analysis revealed non-white race, large lesion size (greater than 4 cm), platelet count greater than 300,000/microL, and the presence of nodal metastases to be factors related to poor prognosis. A comparison of patients with platelet counts of 300,000/microL or less and patients with platelet counts greater than 300,000/microL revealed no difference with regard to race, nodal metastases, and median age. However, a larger percentage of women with a platelet count greater than 300,000/microL had large lesion size (29 of 60, versus 32 of 114 with a count of 300,000/microL or less). In a multivariate analysis, after adjusting for age, race, the presence of nodal metastases, and lesion size, high platelet count was still associated with poor prognosis (P = .04).


An elevated platelet count is an independent prognostic factor for poor survival in patients with early-stage cervical cancer.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center